Clinical Trials
All Clinical Trials - Page 19 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05912621Phase 2Recruiting
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
Tirzepatide
- NCT05983198Phase 1Active Not Recruiting
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Gonadorelin
- NCT06069622N/ARecruiting
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
Semaglutide
- NCT06333080N/ATerminated
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Semaglutide
- NCT05952882Phase 3Unknown
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Liraglutide
- NCT06501326Phase 4Unknown
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Liraglutide
- NCT07576036N/AEnrolling By Invitation
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
Desmopressin
- NCT05918302Phase 3Recruiting
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Octreotide
- NCT05938712Phase 2Recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
Semaglutide
- NCT05901467Phase 1Terminated
Recall by Genotype: Neuropeptide Stimulation
Kisspeptin
- NCT06247748Phase 1Completed
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Exenatide
- NCT06085482Phase 1Completed
A Phase I Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05879926Phase 3Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Gonadorelin
- NCT06015893Phase 2Active Not Recruiting
Semaglutide Therapy for Alcohol Reduction (STAR)
Semaglutide
- NCT06075667Phase 3Active Not Recruiting
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT05788965Phase 2/Phase 3Completed
Semaglutide in CFRD
Semaglutide
- NCT06109649Phase 3Active Not Recruiting
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Afamelanotide
- NCT05971849Phase 1Completed
Dampening the Reproductive Axis With Continuous Kisspeptin
Kisspeptin
- NCT05478707Phase 2Recruiting
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Dulaglutide
- NCT06059118Phase 2Recruiting
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Gonadorelin
- NCT05751720Phase 1/Phase 2Unknown
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
Tirzepatide
- NCT03717870N/ANot Yet Recruiting
Surgery and ART For Endometrioma
Gonadorelin
- NCT06097390Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
Semaglutide
- NCT06010004Phase 3Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Orforglipron
- NCT06065540Phase 3Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Semaglutide
- NCT05371028N/ACompleted
A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Teduglutide
- NCT06045221Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Semaglutide
- NCT06037252Phase 2Active Not Recruiting
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Tirzepatide
- NCT06023095Phase 1Completed
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
Orforglipron
- NCT06047548Phase 3Completed
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT06739044Phase 3Completed
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Semaglutide
- NCT06024356N/ACompleted
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT07309094N/ARecruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Tirzepatide
- NCT06041217Phase 3Completed
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
Semaglutide
- NCT06064006Phase 2Completed
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
Amycretin
- NCT05569772Phase 3Recruiting
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Semaglutide
- NCT06049329Phase 1Completed
A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
Amycretin
- NCT06009653Phase 4Withdrawn
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Tirzepatide
- NCT06045260Phase 2Recruiting
"Receptor Radionuclide Therapy With 177Lu-DOTATOC
Octreotide
- NCT06039826Phase 1Completed
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Retatrutide
- NCT05894239Phase 3Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Gonadorelin
- NCT06344247N/AUnknown
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
Semaglutide
- NCT04972721N/ACompleted
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Semaglutide
- NCT06178146Phase 4Unknown
Thymosin Alpha-1 for irAE Secondary to ICIs
Thymosin-Alpha-1
- NCT07374445Phase 4Completed
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Liraglutide
- NCT06331286N/AUnknown
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
Dulaglutide
- NCT06003465Phase 1Completed
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Retatrutide
- NCT05724134Phase 1Completed
Pancreatic Clamp in NAFLD
Octreotide
- NCT06061354Phase 4Unknown
Teriparatide on Maxillary Sinus Floor Osseointegration
Teriparatide
- NCT06062719Phase 2/Phase 3Unknown
Role of Octreotide in Non Variceal Bleeding
Octreotide